Table 2.
Variables | Long COVID | P-value | OR | 95% CI | |
---|---|---|---|---|---|
No | Yes | ||||
Number | 211 (81.15%) | 49 (18.85%) | |||
Age (years) | 46.36 (21.94%) | 57.06 (19.59%) | 0.001 | - | - |
<60 | 143 (67.77%) | 18 (8.53%) | Reference | ||
≥60 | 67 (31.75%) | 31 (14.69%) | <0.001 | 3.676 | 1.920–7.036 |
Gender | |||||
Female | 120 (56.87%) | 35 (71.43%) | 0.064 | 1.896 | 0.963–3.731 |
Male | 91 (43.13%) | 14 (28.57%) | Reference | ||
BMI (kg/m2) | 24.63 (5.84%) | 25.91 (5.66%) | 0.166 | - | - |
<25 | 85 (40.25%) | 28 (57.14%) | Reference | ||
≥25 | 126 (59.72%) | 21 (42.86%) | 0.034 | 0.506 | 0.27–0.949 |
Virus strains | |||||
Delta | 0 | 5 (10.20%) | Reference | ||
Omicron | 211 | 44 (89.80%) | 0.999 | N/A | N/A |
Omicron (BA.1) | 1 (0.47%) | 11 (22.45%) | - | - | - |
Omicron (BA.2) | 116 (54.98%) | 33 (67.35%) | - | - | - |
Omicron (BA.2.12.1) | 3 (1.42%) | 0 (0.00%) | - | - | - |
Omicron (BA.2/BA.5) | 1 (0.47%) | 0 (0.00%) | - | - | - |
Omicron (BA.4) | 6 (2.84%) | 0 (0.00%) | - | - | - |
Omicron (BA.4/BA.5) | 2 (0.95%) | 0 (0.00%) | - | - | - |
Omicron (BA.5) | 82 (38.86%) | 0 (0.00%) | - | - | - |
Vaccination status | |||||
No | 26 (12.32%) | 5 (10.20%) | 0.681 | 0.809 | 0.294–2.224 |
Yes | 185 (87.68%) | 44 (89.80%) | Reference | ||
Comorbidities | |||||
Chronic diseases | |||||
No | 132 (62.56%) | 14 (28.57%) | Reference | ||
Yes | 79 (37.44%) | 35 (71.43%) | <0.001 | 4.177 | 2.117–8.242 |
Diabetes mellites | |||||
No | 181 (85.78%) | 32 (65.31%) | Reference | ||
Yes | 30 (14.22%) | 17 (34.69%) | 0.001 | 3.205 | 1.586–6.479 |
Hypertension | |||||
No | 177 (83.87%) | 20 (40.82%) | Reference | ||
Yes | 34 (16.11%) | 29 (59.18%) | <0.001 | 7.549 | 3.833–14.865 |
Infectious diseases | |||||
No | 210 (99.53%) | 49 (100.00%) | Reference | ||
Yes | 1 (0.47%) | 0 (0.00%) | 1.000 | N/A | N/A |
P-values marked with bold indicate statistically significant differences between the groups.
Abbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; N/A, not available; OR, odds ratio.